Wu K - Search Results

1

Progression and prognostic value of ECT2 in non-small-cell lung cancer and its correlation with PCNA.

Bai X, Yi M, Xia X, Yu S, Zheng X, Wu K. Bai X, et al. Among authors: wu k. Cancer Manag Res. 2018 Sep 28;10:4039-4050. doi: 10.2147/CMAR.S170033. eCollection 2018. Cancer Manag Res. 2018. PMID: 30319288 Free PMC article.

2

Cell fate factor DACH1 represses YB-1-mediated oncogenic transcription and translation.

Wu K, Chen K, Wang C, Jiao X, Wang L, Zhou J, Wang J, Li Z, Addya S, Sorensen PH, Lisanti MP, Quong A, Ertel A, Pestell RG. Wu K, et al. Cancer Res. 2014 Feb 1;74(3):829-39. doi: 10.1158/0008-5472.CAN-13-2466. Epub 2013 Dec 12. Cancer Res. 2014. PMID: 24335958 Free PMC article.

3

Meta-analysis reveals the correlation of Notch signaling with non-small cell lung cancer progression and prognosis.

Yuan X, Wu H, Xu H, Han N, Chu Q, Yu S, Chen Y, Wu K. Yuan X, et al. Among authors: wu h, wu k. Sci Rep. 2015 May 21;5:10338. doi: 10.1038/srep10338. Sci Rep. 2015. PMID: 25996086 Free PMC article.

4

Non-invasive approaches to monitor EGFR-TKI treatment in non-small-cell lung cancer.

Sun W, Yuan X, Tian Y, Wu H, Xu H, Hu G, Wu K. Sun W, et al. Among authors: wu h, wu k. J Hematol Oncol. 2015 Jul 31;8:95. doi: 10.1186/s13045-015-0193-6. J Hematol Oncol. 2015. PMID: 26227959 Free PMC article. Review.

5

Emerging roles of Nrf2 signal in non-small cell lung cancer.

Tian Y, Liu Q, He X, Yuan X, Chen Y, Chu Q, Wu K. Tian Y, et al. Among authors: wu k. J Hematol Oncol. 2016 Feb 27;9:14. doi: 10.1186/s13045-016-0246-5. J Hematol Oncol. 2016. PMID: 26922479 Free PMC article. Review.

6

The expression profile and clinic significance of the SIX family in non-small cell lung cancer.

Liu Q, Li A, Tian Y, Liu Y, Li T, Zhang C, Wu JD, Han X, Wu K. Liu Q, et al. Among authors: wu jd, wu k. J Hematol Oncol. 2016 Nov 8;9(1):119. doi: 10.1186/s13045-016-0339-1. J Hematol Oncol. 2016. PMID: 27821176 Free PMC article. Review.

7

Chimeric antigen receptor T cells: a novel therapy for solid tumors.

Yu S, Li A, Liu Q, Li T, Yuan X, Han X, Wu K. Yu S, et al. Among authors: wu k. J Hematol Oncol. 2017 Mar 29;10(1):78. doi: 10.1186/s13045-017-0444-9. J Hematol Oncol. 2017. PMID: 28356156 Free PMC article. Review.

8

Recent advances of highly selective CDK4/6 inhibitors in breast cancer.

Xu H, Yu S, Liu Q, Yuan X, Mani S, Pestell RG, Wu K. Xu H, et al. Among authors: wu k. J Hematol Oncol. 2017 Apr 24;10(1):97. doi: 10.1186/s13045-017-0467-2. J Hematol Oncol. 2017. PMID: 28438180 Free PMC article. Review.

9

Targeting interlukin-6 to relieve immunosuppression in tumor microenvironment.

Liu Q, Yu S, Li A, Xu H, Han X, Wu K. Liu Q, et al. Among authors: wu k. Tumour Biol. 2017 Jun;39(6):1010428317712445. doi: 10.1177/1010428317712445. Tumour Biol. 2017. PMID: 28639898 Free article. Review.

10

DACH1 suppresses breast cancer as a negative regulator of CD44.

Xu H, Yu S, Yuan X, Xiong J, Kuang D, Pestell RG, Wu K. Xu H, et al. Among authors: wu k. Sci Rep. 2017 Jun 28;7(1):4361. doi: 10.1038/s41598-017-04709-2. Sci Rep. 2017. PMID: 28659634 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,478 results

Search Page

Filters